Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Clinical trial NCT00567567 · COMPLETED

Trial details

NCT number: NCT00567567
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Recurrent Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma

Start date: 2007-11-05
Primary completion: 2015-02-27
Enrollment: 665

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.